P
Penina Haber
Researcher at Centers for Disease Control and Prevention
Publications - 60
Citations - 4231
Penina Haber is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Vaccination & Adverse Event Reporting System. The author has an hindex of 30, co-authored 60 publications receiving 3761 citations.
Papers
More filters
Journal ArticleDOI
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Tamar Lasky,Gina J. Terracciano,Laurence S. Magder,Carol L. Koski,Michael F. Ballesteros,Denis Nash,Shelley Clark,Penina Haber,Paul D. Stolley,Lawrence B. Schonberger,Robert T. Chen +10 more
TL;DR: There was no increase in the risk of vaccine-associated Guillain-Barré syndrome from 1992-1993 to 1993-1994 and for the two seasons combined, the adjusted relative risk of 1.7 suggests slightly more than one additional case of Guillian-B Barré syndrome per million persons vaccinated against influenza.
Journal ArticleDOI
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Sarah Schillie,Claudia Vellozzi,Arthur Reingold,Aaron M. Harris,Penina Haber,John W. Ward,Noele P. Nelson +6 more
TL;DR: This report updates and summarizes previously published recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC regarding the prevention of HBV infection in the United States and provides CDC guidance for postexposure prophylaxis following occupational and other exposures.
Journal Article
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Weigong Zhou,Vitali Pool,John K. Iskander,Roseanne English-Bullard,Robert Ball,Robert P. Wise,Penina Haber,Robert Pless,Gina T. Mootrey,Susan S. Ellenberg,M. Miles Braun,Robert T. Chen +11 more
TL;DR: This report summarizes the adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) from January 1, 1991, through December 31, 2001, and indicates that the most commonly reported adverse event was fever, which appeared in 25.8% of all reports.
Journal ArticleDOI
Guillain-Barré Syndrome Following Influenza Vaccination
Penina Haber,Frank DeStefano,Fredrick J. Angulo,John K. Iskander,Sean V. Shadomy,Eric Weintraub,Robert T. Chen +6 more
TL;DR: From 1990 to 2003, VAERS reporting rates of GBS after influenza vaccination decreased, and the long onset interval and low prevalence of other preexisting illnesses are consistent with a possible causal association between GBS and influenza vaccine.
Journal ArticleDOI
Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
TL;DR: Adverse event reporting rates have been reasonably constant over time and provide useful information if pandemic vaccine is rapidly distributed and pre-licensure data are limited.